The pharmaceutical landscape is witnessing a change with the arrival of GLP-1 transdermal systems . These cutting-edge formulations offer a potential alternative to administering glucagon-like peptide-1 https://aoifedqca791709.azzablog.com/41381669/glp-1-patches-a-new-way-to-control-blood-sugar